Mirror bacteria, theoretical organisms composed of chiral molecules that are mirror images of those found in natural life forms, have sparked significant debate within the scientific community. These organisms hinge on the concept of chirality, where "right-handed" amino acids and "left-handed"
The field of immunotherapy has witnessed a groundbreaking advancement with the introduction of TRACeR-I, a novel protein platform designed to enhance antigen recognition. This innovative platform promises broad HLA compatibility, significantly improving immune response engineering and targeting
A consortium of 38 leading scientists spanning various disciplines has issued a stark warning regarding the potential creation of “mirror bacteria” – synthetic organisms with reversed molecular structures. This concept, while seemingly out of a science fiction plot, poses significant risks that
Synthetic biology represents a revolutionary discipline that applies engineering principles to biology, aiming to develop cells into sophisticated micro-factories capable of producing essential materials. With the potential to spearhead advancements across numerous industries—including medicine,
Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
The development of synthetic intramembrane proteolysis receptors (SNIPRs) engineered by researchers in the United States could be a game-changer for CAR T-cell cancer therapies. This groundbreaking advancement introduces a novel methodology to enhance the precision and safety of CAR T-cell
